RSS
JOBS
SITE MAP
HOME
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
RESOURCE CENTER
SUBSCRIBE
SUBSCRIBE ASIA DIGEST
NEWS
|
FEATURES
|
PEOPLE
|
EVENTS
|
R & D
|
POLICIES
|
PRODUCTS
|
TRENDS & ANALYSIS
Friday, September 3, 2010
SEARCH
BIO
AUSTRALIA
BIO
CHINA
BIO
INDIA
BIO
INDONESIA
BIO
JAPAN
BIO
KOREA
BIO
MALAYSIA
BIO
NEW ZEALAND
BIO
PHILIPPINES
BIO
SINGAPORE
BIO
TAIWAN
BIO
THAILAND
NEWS
Halcygen teams with Pan-Malayan for S'pore market
HalcyGen has signed a distribution agreement with Pan- Malayan Pharmaceuticals for the distribution of Doryx, Astrix and Eryc in Singapore
Somaxon, P&G to co-promote Silenor
Somaxon and Procter & Gamble have entered into a co-promotion agreement for Silenor (doxepin), a newly-approved treatment for insomnia characterized by difficulty with sleep maintenance
TODAY'S
NEWS
Scientists discover protein that fuels Alzheimer's disease
Agensys initiates phase I of renal cancer drug
Pfizer to acquire drug developer FoldRx
Varian establishes radiotherapy training center in India
Yongye enters into $59 mn revolving credit facilities
Ono licenses Concordia's cancer drug in Japan
Advertisement
Digital Mag
Issue: July, 2010
Current Issue
View / Download
Top Story
Are biofuels poised for a leap?
Get the latest news on life sciences in your mail box
Name
E-Mail Id
Advertisement
NEWS
Agensys initiates phase I of renal cancer drug
Astellas' affiliate has started trials of AGS-16M8F an antibody-drug conjugate for treating metastatic renal cancer
Pfizer to acquire drug developer FoldRx
US-based pharma giant Pfizer agreed to acquire privately held drug discovery and clinical development company FoldRx Pharmaceuticals
Ono licenses Concordia's cancer drug in Japan
Concordia has granted Ono the exclusive rights to develop and commercialize salirasib in Japan
Sun Pharma's NJ unit receives warning from FDA
US Food and Drug Administration has warned the US unit of Indian drugmaker Sun Pharmaceutical for violations of current good manufacturing practice at a plant in New Jersey.
GE healthcare, iBio, CMB execute business development and marketing agreement
GE Healthcare, iBio and Fraunhofer US Center for Molecular Biotechnology have entered into an agreement to jointly develop and globally market manufacturing solutions for biopharmaceuticals and vaccines
Survey finds malnutrition risk among elderly in Singapore
New data presented from a nationwide survey on the dietary habits of elderly Singaporeans revealed that nearly 30 percent of the elderly are at moderate to high risk of malnutrition.
Rondaxe, Thomson team up to provide better solutions for API costing
Thomson Reuters and Rondaxe Enterprises have announced an agreement that will enable professionals working in the generic drug sector to better estimate the cost of manufacturing active pharmaceutical ingredients (API).
BARDA funds new treatment for illness from acute radiation
Biomedical Advanced Research and Development Authority has awarded a $153 million contract to Cellerant Therapeutics to continue developing a new way to treat an illness caused by exposure to high levels of ionizing radiation.
9th Annual BIO Investor Forum in SF from Oct.5
BIO has announced the preliminary set of speakers who will be featured on the Therapeutic Workshops during the 9th Annual BIO Investor Forum.
QRxPharma analyzes MoxDuoIR's phase III study
The analysis has indicated that the planned sample size of 140 patients has greater than 90 percent power to detect differences of analgesic effect
More
Advertisement
BioSpectrumAsia.com
BioSpectrumIndia.com
Web
About BioSpectrum
|
How to Advertise
|
Jobs at BioSpectrum
|
Jobs at CyberMedia
|
Contact Us
|
Privacy Statement
CyberMedia Network Websites
[
Voice&Data
] [
PCQuest
] [
CIOL
] [
Dataquest
] [
Living Digital
] [
IDC India
]
[
DQ Channels
] [
The DQweek
] [
DARE
]
[
CyberMedia Events
] [
CyberMedia Digital
] [
Cyber Astro
] [
CyberMedia India
] [
Global Services
] [
BioSpectrum
]
Copyrights are reserved for
BioSpectrum
; Designed by :
Altered Black
